In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

4D Science GmbH

Latest From 4D Science GmbH

Private Equity Firm EQT Hopes Higher Cash Offer Will Win It Karo Pharma

Private equity firm EQT hopes a higher cash offer for Swedish specialty pharma group Karo Pharma than the one it made two months ago will persuade reluctant shareholders in the biotech to now sell their holdings.

M & A Commercial

Deals Shaping The Medical Industry, November 2013

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced September through October 2013.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Germany
  • Parent & Subsidiaries
  • 4D Science GmbH
  • Senior Management
  • Jorg Distler, MD, CEO
  • Contact Info
  • 4D Science GmbH
    Birkenallee 126
    Bubenrueth, 91088
    Germany
Advertisement
Advertisement
UsernamePublicRestriction

Register